Related Experiment Video
Updated: Mar 21, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
The Pulmonary Hypertension Consult: Clinical and Coding Considerations.
Jason S Fritz1, K Akaya Smith1
1Department of Medicine, Pulmonary, Allergy, and Critical Care Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Pulmonary hypertension (PH) is a complex condition with increasing research and therapies. This review details PH classification, diagnosis, and adult patient evaluation, including billing considerations.
Area of Science:
- Cardiology
- Pulmonology
- Medical Diagnostics
Background:
- Pulmonary hypertension (PH) is a significant cause of illness and death.
- Research and treatments for PH have rapidly advanced in the last two decades.
- PH, defined as mean pulmonary arterial pressure ≥ 25 mm Hg, comprises diverse disease processes.
Purpose of the Study:
- To review the current classification systems for pulmonary hypertension.
- To outline a methodical approach for the diagnostic evaluation of PH in adults.
- To discuss associated billing and coding considerations for PH evaluation.
Main Methods:
- Review of existing literature on PH classification and diagnosis.
- Analysis of diagnostic criteria and methodologies for PH.
- Examination of coding and billing practices related to PH evaluation.
Main Results:
- PH classification has evolved from primary/secondary to grouping by clinical features and mechanisms.
- A systematic diagnostic approach is crucial for accurate PH identification and treatment.
- Understanding the heterogeneity of PH is key for effective management.
Conclusions:
- Accurate classification and timely diagnosis are essential for appropriate PH treatment.
- A comprehensive evaluation, including physiological classification, is necessary for adult patients with PH.
- Consideration of billing and coding is important in the overall PH evaluation process.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism I: Introduction

